Invoking MCP tool get_variant_evidence with input {"molecularProfileName": null, "diseaseName": "Head and Neck Squamous Cell Carcinoma", "therapyName": "Radiation Therapy", "significance": "RESISTANCE"}
MCP tool get_variant_evidence returned meta=None content=[TextContent(type='text', text='{
  "Field Descriptions": "evidenceType: Category describing the type of clinical or biological evidence (e.g., predictive, diagnostic).\
evidenceDirection: Indicates whether the evidence supports or refutes the association.\
significance: The clinical relevance of the evidence.\
description: Detailed summary of the evidence from CIViC curators.\
evidenceLevel: Describes the robustness of the study type. A - Validated association, B - Clinical evidence, C - Case study, D - Preclinical evidence, and E - Inferential association\
evidenceRating: Quality score assigned to the evidence by curators (scored 1-5).\
url: Direct link to the CIViC record for this evidence item.\
When returning information to users you MUST cite URLs used for specific information.",
  "API Results": [
    {
      "status": "ACCEPTED",
      "evidenceType": "PREDICTIVE",
      "evidenceDirection": "SUPPORTS",
      "significance": "RESISTANCE",
      "molecularProfile": {
        "variants": [
          {
            "name": "Expression",
            "feature": {
              "name": "CD274"
            }
          }
        ]
      },
      "disease": {
        "displayName": "Head And Neck Squamous Cell Carcinoma"
      },
      "therapies": [
        {
          "name": "Radiation Therapy"
        }
      ],
      "variantOrigin": "NA",
      "description": "Radiation-resistant cell lines exhibited upregulation and increased activation of Axl, PI3 kinase signalling as well as increased expression of PD-L1. In 3 cohorts of HPV-negative head and neck squamous cell carcinoma patient samples evaluated with different methods [reverse phase protein array (N=68), mRNA expression array (N=97) or immunohistochemistry (N=114), respectively], increased expression of PD-L1 was also correlated with local failure following radiotherapy as compared to the PD-L1–low expression group (P = 0.01, 1.9 × 10−3, and 9 × 10−4, respectively).",
      "evidenceLevel": "B",
      "evidenceRating": 4,
      "url": "https://identifiers.org/civic.eid:3000"
    }
  ]
}', annotations=None, meta=None)] structuredContent=None isError=False
Invoking MCP tool get_variant_assertions with input {"molecularProfileName":null,"diseaseName":"Head and Neck Squamous Cell Carcinoma","therapyName":"Radiation Therapy","significance":"RESISTANCE"}
MCP tool get_variant_assertions returned meta=None content=[TextContent(type='text', text='{
  "errors": [
    {
      "message": "Variable $molecularProfileName of type String! was provided invalid value",
      "locations": [
        {
          "line": 2,
          "column": 22
        }
      ],
      "extensions": {
        "value": null,
        "problems": [
          {
            "path": [],
            "explanation": "Expected value to not be null"
          }
        ]
      }
    }
  ]
}', annotations=None, meta=None)] structuredContent=None isError=False
### LLM OUTPUT ###
CD274
